Novastep signed an agreement with Vivex Biomedical to launch bioSTART® Tissue Repair products, offering amniotic membranes and liquid to support foot and ankle procedures in clinical and outpatient settings throughout the U.S. Novastep will also add demineralized bone matrices to its portfolio.
Novastep offers implants, biologics, instruments and medical education focused on the foot and ankle. The company is a subsidiary of Amplitude Surgical, which received Austrialian regulatory clearance in late 2015 to market the Novastep product range.
Vivex markets cellular therapies to treat orthopaedic, spine, wound and soft tissue indications. Within 1Q16, the company signed agreements with Arthrex and Xtant Medical, expanding the distribution of its products with these partnerships.
Novastep signed an agreement with Vivex Biomedical to launch bioSTART® Tissue Repair products, offering amniotic membranes and liquid to support foot and ankle procedures in clinical and outpatient settings throughout the U.S. Novastep will also add demineralized bone matrices to its portfolio.
Novastep offers implants, biologics,...
Novastep signed an agreement with Vivex Biomedical to launch bioSTART® Tissue Repair products, offering amniotic membranes and liquid to support foot and ankle procedures in clinical and outpatient settings throughout the U.S. Novastep will also add demineralized bone matrices to its portfolio.
Novastep offers implants, biologics, instruments and medical education focused on the foot and ankle. The company is a subsidiary of Amplitude Surgical, which received Austrialian regulatory clearance in late 2015 to market the Novastep product range.
Vivex markets cellular therapies to treat orthopaedic, spine, wound and soft tissue indications. Within 1Q16, the company signed agreements with Arthrex and Xtant Medical, expanding the distribution of its products with these partnerships.
Copy to clipboard 
